Rhythm Pharmaceuticals
RYTM
RYTM
168 hedge funds and large institutions have $3.08B invested in Rhythm Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 42 increasing their positions, 63 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
+25
Holders Change %
+17.48%
% of All Funds
2.46%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.15%
New
44
Increased
42
Reduced
63
Closed
19
Calls
$50M
Puts
$3.11M
Net Calls
+$46.9M
Net Calls Change
+$37.3M
Top Buyers
Top Sellers
| 1 |
Alkeon Capital Management
New York
|
$0 |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
$80.4M |
| 3 |
VA
VR Adviser
New York
|
$22.8M |
| 4 |
CC
Commodore Capital
New York
|
$71.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
$28.6M |
